UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

The oncologist (Dayton, Ohio), 2010-09, Vol.15 (9), p.994-1001

2010

Volltextzugriff (PDF)

Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

Blood cancer journal (New York), 2020-05, Vol.10 (5), p.56-56, Article 56

2020

Volltextzugriff (PDF)

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Clinical cancer research, 2021-07, Vol.27 (13), p.3515-3521

2021

Volltextzugriff (PDF)

FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (2), p.149-157

2022

Volltextzugriff (PDF)

Survival of adults with acute lymphoblastic leukemia in Germany and the United States

PloS one, 2014-01, Vol.9 (1), p.e85554-e85554

2014

Volltextzugriff (PDF)

Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010

Haematologica (Roma), 2009-02, Vol.94 (2), p.270-275

2009

Volltextzugriff (PDF)

Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups

Haematologica (Roma), 2013-02, Vol.98 (2), p.222-229

2013

Volltextzugriff (PDF)

Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century

British journal of haematology, 2015-10, Vol.171 (2), p.189-196

2015

Volltextzugriff (PDF)

Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century

Haematologica (Roma), 2008-04, Vol.93 (4), p.594-600

2008

Volltextzugriff (PDF)

Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century

British journal of haematology, 2014-03, Vol.164 (6), p.851-857

2014

Volltextzugriff (PDF)

Subsite-specific colorectal cancer risk in the colorectal endoscopy era

Gastrointestinal endoscopy, 2012-03, Vol.75 (3), p.621-630.e1

2012

Volltextzugriff (PDF)

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

The oncologist (Dayton, Ohio), 2018-06, Vol.23 (6), p.734-739

2018

Volltextzugriff (PDF)

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

Blood advances, 2018-01, Vol.2 (2), p.116-119

2018

Volltextzugriff (PDF)

Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level

Haematologica (Roma), 2008-10, Vol.93 (10), p.1544-1549

2008

Volltextzugriff (PDF)

Recent major improvement in long-term survival of younger patients with multiple myeloma

Blood, 2008-03, Vol.111 (5), p.2521-2526

2008

Volltextzugriff (PDF)

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Blood, 2024-07, Vol.144 (2), p.206-215

2024

Volltextzugriff (PDF)

Determining the role of smoking in myeloproliferative neoplasms: is it a matter of picking the right control group?

European journal of haematology, 2016-07, Vol.97 (1), p.3-4

Pulte, Dianne

2016

Volltextzugriff (PDF)

Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis

Diseases of the colon & rectum, 2018-05, Vol.61 (5), p.538-546

2018

Volltextzugriff (PDF)

CD39/NTPDase-1 activity and expression in normal leukocytes

Thrombosis research, 2007, Vol.121 (3), p.309-317

2007

Volltextzugriff (PDF)

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1366-1371

2018

Volltextzugriff (PDF)

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Journal of clinical oncology, 2022-03, Vol.40 (8), p.847-854

2022

Volltextzugriff (PDF)

Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally

Journal of clinical oncology, 2017-02, Vol.35 (6), p.695-696

2017

Volltextzugriff (PDF)

Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time

Leukemia & lymphoma, 2022-07, Vol.63 (8), p.1964-1969

2022

Volltextzugriff (PDF)

Case series of octogenarians with sickle cell disease

Blood, 2016-11, Vol.128 (19), p.2367-2369

2016

Volltextzugriff (PDF)

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

Blood, 2009-02, Vol.113 (7), p.1408-1411

2009

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(117)
Berichte
(2)

Sprache

Englisch
(119)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial

Survival of adults with acute lymphoblastic leukemia in Germany and the United States

Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010

Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups

Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century

Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century

Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century

Subsite-specific colorectal cancer risk in the colorectal endoscopy era

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level

Recent major improvement in long-term survival of younger patients with multiple myeloma

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Determining the role of smoking in myeloproliferative neoplasms: is it a matter of picking the right control group?

Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis

CD39/NTPDase-1 activity and expression in normal leukocytes

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally

Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time

Case series of octogenarians with sickle cell disease

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

Suchergebnisse filtern